Future Science Group
Browse
supplementary_information_revision.docx (1.5 MB)
Download file

Cost-effectiveness analysis of nivolumab plus cabozantinib versus sunitinib as first-line therapy in advanced RCC.

Download (1.5 MB)
figure
posted on 2022-06-27, 07:34 authored by Jianxin Pang, Peihao Wu, Yanqing Jiang, Junyan Wu, Kaifeng Qiu, Ruizhe Liu

 Figure S1. Kaplan–Meier curves and modelled curves. 

History

Usage metrics

    Immunotherapy

    Exports